Abstract
Aims: To investigate possible use of Glycosylphosphatidylinositol-specific phospholipase C (GPIPLC) as a target protein for the development of vaccine against Trypanosoma brucei brucei infection was investigated. Study Design: GPI-PLC from T. brucei brucei was purified, characterized and the protein was used as antigen in raising antibody against the parasite
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of TROPICAL DISEASE & Health
Paper Title
Journal
Date
